394 related articles for article (PubMed ID: 29566728)
1. The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.
Knight JA; Blackmore KM; Fan J; Malone KE; John EM; Lynch CF; Vachon CM; Bernstein L; Brooks JD; Reiner AS; Liang X; Woods M; ; Bernstein JL
Breast Cancer Res; 2018 Mar; 20(1):23. PubMed ID: 29566728
[TBL] [Abstract][Full Text] [Related]
2. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
[TBL] [Abstract][Full Text] [Related]
3. Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.
Knight JA; Fan J; Malone KE; John EM; Lynch CF; Langballe R; Bernstein L; Shore RE; Brooks JD; Reiner AS; Woods M; Liang X; Bernstein JL;
Int J Cancer; 2017 Sep; 141(5):916-924. PubMed ID: 28524234
[TBL] [Abstract][Full Text] [Related]
4. Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case-control study.
Velásquez García HA; Sobolev BG; Gotay CC; Wilson CM; Lohrisch CA; Lai AS; Aronson KJ; Spinelli JJ
Breast Cancer Res Treat; 2018 Jul; 170(1):159-168. PubMed ID: 29516373
[TBL] [Abstract][Full Text] [Related]
5. Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholds.
Watt GP; Knight JA; Nguyen TL; Reiner AS; Malone KE; John EM; Lynch CF; Brooks JD; Woods M; Liang X; Bernstein L; Pike MC; Hopper JL; Bernstein JL
Int J Cancer; 2022 Oct; 151(8):1304-1309. PubMed ID: 35315524
[TBL] [Abstract][Full Text] [Related]
6. Mammographic breast density is associated with the development of contralateral breast cancer.
Raghavendra A; Sinha AK; Le-Petross HT; Garg N; Hsu L; Patangan M; Bevers TB; Shen Y; Banu A; Tripathy D; Bedrosian I; Barcenas CH
Cancer; 2017 Jun; 123(11):1935-1940. PubMed ID: 28135395
[TBL] [Abstract][Full Text] [Related]
7. Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study.
Sandberg ME; Li J; Hall P; Hartman M; dos-Santos-Silva I; Humphreys K; Czene K
Breast Cancer Res; 2013; 15(4):R57. PubMed ID: 23876209
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM
J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019
[TBL] [Abstract][Full Text] [Related]
9. Mammographic Density Change and Risk of Breast Cancer.
Azam S; Eriksson M; Sjölander A; Hellgren R; Gabrielson M; Czene K; Hall P
J Natl Cancer Inst; 2020 Apr; 112(4):391-399. PubMed ID: 31298705
[TBL] [Abstract][Full Text] [Related]
10. A comparison of five methods of measuring mammographic density: a case-control study.
Astley SM; Harkness EF; Sergeant JC; Warwick J; Stavrinos P; Warren R; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Brentnall AR; Cuzick J; Howell T; Evans DG
Breast Cancer Res; 2018 Feb; 20(1):10. PubMed ID: 29402289
[TBL] [Abstract][Full Text] [Related]
11. Reproductive history and risk of second primary breast cancer: the WECARE study.
Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.
Nyante SJ; Sherman ME; Pfeiffer RM; Berrington de Gonzalez A; Brinton LA; Aiello Bowles EJ; Hoover RN; Glass A; Gierach GL
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663687
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen.
Nyante SJ; Sherman ME; Pfeiffer RM; Berrington de Gonzalez A; Brinton LA; Bowles EJ; Hoover RN; Glass A; Gierach GL
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):212-6. PubMed ID: 26545407
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal trends in mammographic percent density and breast cancer risk.
Vachon CM; Pankratz VS; Scott CG; Maloney SD; Ghosh K; Brandt KR; Milanese T; Carston MJ; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):921-8. PubMed ID: 17507617
[TBL] [Abstract][Full Text] [Related]
15. Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years.
Brentnall AR; Warren R; Harkness EF; Astley SM; Wiseman J; Fox J; Fox L; Eriksson M; Hall P; Cuzick J; Evans DG; Howell A
Breast Cancer Res; 2020 Sep; 22(1):101. PubMed ID: 32993747
[TBL] [Abstract][Full Text] [Related]
16. Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk.
Hudson S; Vik Hjerkind K; Vinnicombe S; Allen S; Trewin C; Ursin G; Dos-Santos-Silva I; De Stavola BL
Breast Cancer Res; 2018 Dec; 20(1):156. PubMed ID: 30594212
[TBL] [Abstract][Full Text] [Related]
17. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL;
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for contralateral breast cancer in Chennai (Madras), India.
Gajalakshmi CK; Shanta V; Hakama M
Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
[TBL] [Abstract][Full Text] [Related]
20. The distribution and determinants of mammographic density measures in Western Australian aboriginal women.
McLean K; Darcey E; Cadby G; Lund H; Pilkington L; Redfern A; Thompson S; Saunders C; Wylie E; Stone J
Breast Cancer Res; 2019 Feb; 21(1):33. PubMed ID: 30819215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
